
|
Boston Scientific Corporation. The Group's principal activities are developing, manufacturing and marketing medical devices. It's products are offered for sale through three business groups: Cardiovascular, Endosurgery and Neuromodulation. The Cardiovascular segment offers products and technologies for use in interventional cardiology, peripheral ... More
|
|
|
|
First Call expects 0.13 EPS for next quarter.
The current Price Target for BSX is $10.70.

| 8.16 Last |
---- Today’s Change |
-- Today’s Open |
-- Day High |
-- Day Low |
-- Volume |
| Quotes delayed by at least 20 minutes | |||||
BSX
IndustryMouse over chart for more details